Literature DB >> 16728715

HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

John C Marecki1, Carlyne D Cool, Jane E Parr, Virginia E Beckey, Paul A Luciw, Alice F Tarantal, Angela Carville, Richard P Shannon, Adela Cota-Gomez, Rubin M Tuder, Norbert F Voelkel, Sonia C Flores.   

Abstract

RATIONALE: HIV-infected patients with pulmonary arterial hypertension have histologic manifestations that are indistinguishable from those found in patients with idiopathic pulmonary arterial hypertension. In addition, the role of pleiotropic viral proteins in the development of plexiform lesions in HIV-related pulmonary hypertension (HRPH) has not been explored. Simian immunodeficiency virus (SIV) infection of macaques has been found to closely recapitulate many of the characteristic features of HIV infection, and thus hallmarks of pulmonary arterial hypertension should also be found in this nonhuman primate model of HIV.
OBJECTIVES: To determine whether pulmonary arterial lesions were present in archived SIV-infected macaque lung tissues from Johns Hopkins University and two National Primate Research Centers.
METHODS: Archived macaque and human lung sections were examined via immunohistochemistry for evidence of complex vascular lesions.
RESULTS: Complex plexiform-like lesions characterized by lumenal obliteration, intimal disruption, medial hypertrophy, thrombosis, and recanalized lumena were found exclusively in animals infected with SHIV-nef (a chimeric viral construct containing the HIV nef gene in an SIV backbone), but not in animals infected with SIV. The mass of cells in the lesions were factor VIII positive, and contained cells positive for muscle-specific and smooth muscle actins. Lung mononuclear cells were positive for HIV Nef, suggesting viral replication. Endothelial cells in both the SHIV-nef macaques and patients with HRPH, but not in patients with idiopathic pulmonary arterial hypertension, were also Nef positive.
CONCLUSIONS: The discovery of complex vascular lesions in SHIV-nef- but not SIV-infected animals, and the presence of Nef in the vascular cells of patients with HRPH, suggest that Nef plays a key role in the development of severe pulmonary arterial disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728715      PMCID: PMC2648120          DOI: 10.1164/rccm.200601-005OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  42 in total

1.  Vascular endothelial growth factor receptor blockade by SU5416 combined with pulsatile shear stress causes apoptosis and subsequent proliferation of apoptosis-resistant endothelial cells.

Authors:  Seiichiro Sakao; Laimute Taraseviciene-Stewart; Jong Deog Lee; Kathy Wood; Carlyne D Cool; Norbert F Voelkel
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

2.  Evidence for vascular remodeling in the lungs of macaques infected with simian immunodeficiency virus/HIV NEF recombinant virus.

Authors:  John Marecki; Carlyne Cool; Norbert Voelkel; Paul Luciw; Sonia Flores
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

3.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

4.  Pulmonary hypertension.

Authors:  John H Newman
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

5.  The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.

Authors:  H Cheng; J P Hoxie; W P Parks
Journal:  Virology       Date:  1999-11-10       Impact factor: 3.616

Review 6.  Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments.

Authors:  Koen K A Van Rompay
Journal:  AIDS Rev       Date:  2005 Apr-Jun       Impact factor: 2.500

7.  Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Mehrnush Kalayeh; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

Authors:  Xugang Qiao; Bing He; April Chiu; Daniel M Knowles; Amy Chadburn; Andrea Cerutti
Journal:  Nat Immunol       Date:  2006-01-22       Impact factor: 25.606

9.  SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.

Authors:  C P Mandell; R A Reyes; K Cho; E T Sawai; A L Fang; K A Schmidt; P A Luciw
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

10.  Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Virginie Gressin; Rudolf Speich; Peter S Macdonald; Milos Opravil; David A Cooper; Thierry Fourme; Marc Humbert; Jean-François Delfraissy; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2004-08-18       Impact factor: 21.405

View more
  78 in total

1.  Injection drug use as a "second hit" in the pathogenesis of HIV-associated pulmonary hypertension.

Authors:  M Patricia George; Hunter C Champion; Mark T Gladwin; Karen A Norris; Alison Morris
Journal:  Am J Respir Crit Care Med       Date:  2012-06-01       Impact factor: 21.405

Review 2.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

3.  Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.

Authors:  Sharilyn Almodovar; Rob Knight; Amanda A Allshouse; Sarah Roemer; Catherine Lozupone; Daniel McDonald; Jeremy Widmann; Norbert F Voelkel; Robert J Shelton; Edu B Suarez; Kenneth W Hammer; Cecile Goujard; Nicola Petrosillo; Gerald Simonneau; Priscilla Y Hsue; Marc Humbert; Sonia C Flores
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-17       Impact factor: 2.205

4.  Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States.

Authors:  Marshaleen Henriques-Forsythe; Srinadh Annangi; Harrison W Farber
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 5.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

6.  Repression of Nrf2/ARE regulated antioxidant genes and dysregulation of the cellular redox environment by the HIV Transactivator of Transcription.

Authors:  Ari Simenauer; Betelhem Assefa; Jose Rios-Ochoa; Kara Geraci; Brooks Hybertson; Bifeng Gao; Joe McCord; Hanan Elajaili; Eva Nozik-Grayck; Adela Cota-Gomez
Journal:  Free Radic Biol Med       Date:  2019-06-22       Impact factor: 7.376

7.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Hemodynamic and histologic characterization of a swine (Sus scrofa domestica) model of chronic pulmonary arterial hypertension.

Authors:  Abraham Rothman; Robert G Wiencek; Stephanie Davidson; William N Evans; Humberto Restrepo; Valeri Sarukhanov; Amanda Rivera-Begeman; David Mann
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

Review 9.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

10.  Contributors to diffusion impairment in HIV-infected persons.

Authors:  Matthew R Gingo; Jiayan He; Catherine Wittman; Carl Fuhrman; Joseph K Leader; Cathy Kessinger; Lorrie Lucht; William A Slivka; Yingze Zhang; Deborah K McMahon; Frank C Sciurba; Alison Morris
Journal:  Eur Respir J       Date:  2013-02-21       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.